Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancerLieselot Croes(University of Antwerp), Ken Op de Beeck(Antwerp University Hospital)Clinical EpigeneticsApril 11, 201810.1186/s13148-018-0479-yCited by 105SaveCiteExport RISWatch citationsRelated PapersPrimary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies|Annals of Oncology|2017|219